NCT07092449View on ClinicalTrials.gov

Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Gastroesophageal JunctionGastric / Gastroesophageal Junction AdenocarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy

Interventions

DRUG

Neoadjuvant chemo-immunotherapy

Pucotenlimab combined with chemotherapy (Nab-Paclitaxel + Tegafur + Carboplatin)

All Listed Sponsors

lead

Tang-Du Hospital

OTHER

NCT07092449 - Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma | Biotech Hunter | Biotech Hunter